Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcturus Therapeutics Holdings Inc ARCT

Healthcare Biotechnology
Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid... see more

Recent & Breaking News (NDAQ:ARCT)

Alcobra Reports on Productive FDA Meeting for New Lead Product Candidate for ADHD

GlobeNewswire February 6, 2017

Lifshitz & Miller Law Firm Announces Investigation of Alcobra Ltd., Egalet Corporation, Sanderson Farms, Inc., Surgical Care Affiliates, Inc., State Street Corporation, Tenet Healthcare Corp., Vista Outdoor Inc. and Zagg Inc.

PR Newswire February 2, 2017

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Alcobra, Ltd., and Encourages Investors to Contact the Firm

Business Wire January 31, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Alcobra Ltd. Investors

Business Wire January 31, 2017

SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm

Business Wire January 19, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Alcobra, Ltd. and Advises Investors with Losses to Contact the Firm

Business Wire January 19, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of Alcobra Ltd.

Business Wire January 18, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Alcobra, Ltd. and Advises Investors with Losses to Contact the Firm

Business Wire January 17, 2017

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Alcobra Ltd. Investors

Business Wire January 17, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alcobra Ltd. (ADHD)

PR Newswire January 17, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alcobra Ltd. - ADHD

PR Newswire January 17, 2017

Mid-Afternoon Market Update: Crude Oil Up 1.2%; Progress Software Shares Plunge

Benzinga.com  January 17, 2017

12 Biggest Mid-Day Losers For Tuesday

Benzinga.com  January 17, 2017

Mid-Morning Market Update: Markets Open Lower; Morgan Stanley Tops Q4 Estimates

Benzinga.com  January 17, 2017

Alcobra Reports Phase 3 Clinical Trial of MDX in Adults with ADHD Missed Primary Endpoint

GlobeNewswire January 17, 2017

15 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  January 9, 2017

Alcobra Provides Update on Recent FDA Meeting and Path Forward for MDX Clinical Development Program

GlobeNewswire January 9, 2017

18 Biggest Mid-Day Losers For Wednesday

Benzinga.com  December 14, 2016

20 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  December 14, 2016

Alcobra Updates on Recent FDA Meeting

GlobeNewswire December 14, 2016